Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05223608

Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy

Led by Centre Oscar Lambret · Updated on 2026-03-30

651

Participants Needed

1

Research Sites

312 weeks

Total Duration

On this page

Sponsors

C

Centre Oscar Lambret

Lead Sponsor

I

Institut National de la Santé Et de la Recherche Médicale, France

Collaborating Sponsor

AI-Summary

What this Trial Is About

ImmuCCo-1905 is a monocentric interventional study on patients treated by immunotherapy, which consist in establishment of a prospective clinic-biologic database over 5 years, associated with a biobank. This database will allow carrying out works aiming at assessing immunotherapy in real life situation.

CONDITIONS

Official Title

Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Starting first immunotherapy with immune checkpoint inhibitors (anti-PD1, anti-PDL1, or anti-CTLA4) alone or combined at Centre Oscar Lambret
  • Treatment in neo-adjuvant, adjuvant, recurrence, or metastatic setting
  • Histologically confirmed solid tumor
  • Signed written informed consent
  • Covered by the French Social Security system
  • Approval obtained if already enrolled in another immunotherapy clinical trial
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women
  • Previously treated with immune checkpoint inhibitor immunotherapy
  • Under legal guardianship
  • Unable to comply with medical follow-up due to geographical, social, or psychological reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre Oscar Lambret

Lille, Hauts-de-France, France, 59

Actively Recruiting

Loading map...

Research Team

J

Julien THERY

CONTACT

M

Marjane BELMIMOUN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here